Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Agid

Showing results (251-260 of 611) with videos related to

Pageof 62
Sort By:
Journal of Neurochemistry|June 1, 1981
Distribution of catecholamines in the ventral mesencephalon of human brain, with special reference to Parkinson's diseaseF Javoy-Agid, H Taquet, A Ploska, et al.
Journal of Neurochemistry|July 29, 1998
Striatal expression of glutamic acid decarboxylase gene in Alzheimer's diseaseF Boissière, B Faucheux, C Duyckaerts, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1994
Familial Parkinson's disease and polymorphism at the CYP2D6 locusP Mazzetti, E Le Guern, A M Bonnet, et al.
Annals of Neurology|July 14, 2000
D2 dopamine receptor gene in myoclonic dystonia and essential myoclonusA Dürr, J Tassin, M Vidailhet, et al.
Acta Neuropathologica|January 1, 1996
Progressive supranuclear palsy: a clinicopathological study of 21 casesM Verny, K A Jellinger, J J Hauw, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 26, 1977
Lack of involvement of dopaminergic and GABA neurones in the inhbitory effect of harmaline on the activity of striatal cholinergic neurones in the ratF Javoy, C Euvrard, A Herbet, et al.
Brain Research|November 19, 1993
Autoradiographic study of [125I]epidermal growth factor-binding sites in the mesencephalon of control and parkinsonian brains post-mortemJ Villares, B Faucheux, O Strada, et al.
Neuroscience|January 1, 1991
Differential vulnerability of cholinergic projections to the mediodorsal nucleus of the thalamus in senile dementia of Alzheimer type and progressive supranuclear palsyJ P Brandel, E C Hirsch, S Malessa, et al.
Lancet (London, England)|August 4, 1990
Ropinirole without levodopa in Parkinson's diseaseM J Vidailhet, A M Bonnet, S Belal, et al.
Neuroscience|January 1, 1990
Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization studyF Javoy-Agid, E C Hirsch, S Dumas, et al.
Pageof 62

Showing results (251-260 of 611) with videos related to

Sort By:
Pageof 62
Journal of Neurochemistry|June 1, 1981
Distribution of catecholamines in the ventral mesencephalon of human brain, with special reference to Parkinson's diseaseF Javoy-Agid, H Taquet, A Ploska, et al.
Journal of Neurochemistry|July 29, 1998
Striatal expression of glutamic acid decarboxylase gene in Alzheimer's diseaseF Boissière, B Faucheux, C Duyckaerts, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1994
Familial Parkinson's disease and polymorphism at the CYP2D6 locusP Mazzetti, E Le Guern, A M Bonnet, et al.
Annals of Neurology|July 14, 2000
D2 dopamine receptor gene in myoclonic dystonia and essential myoclonusA Dürr, J Tassin, M Vidailhet, et al.
Acta Neuropathologica|January 1, 1996
Progressive supranuclear palsy: a clinicopathological study of 21 casesM Verny, K A Jellinger, J J Hauw, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 26, 1977
Lack of involvement of dopaminergic and GABA neurones in the inhbitory effect of harmaline on the activity of striatal cholinergic neurones in the ratF Javoy, C Euvrard, A Herbet, et al.
Brain Research|November 19, 1993
Autoradiographic study of [125I]epidermal growth factor-binding sites in the mesencephalon of control and parkinsonian brains post-mortemJ Villares, B Faucheux, O Strada, et al.
Neuroscience|January 1, 1991
Differential vulnerability of cholinergic projections to the mediodorsal nucleus of the thalamus in senile dementia of Alzheimer type and progressive supranuclear palsyJ P Brandel, E C Hirsch, S Malessa, et al.
Lancet (London, England)|August 4, 1990
Ropinirole without levodopa in Parkinson's diseaseM J Vidailhet, A M Bonnet, S Belal, et al.
Neuroscience|January 1, 1990
Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization studyF Javoy-Agid, E C Hirsch, S Dumas, et al.
Pageof 62